[HTML][HTML] Expression of a mutant p193/CUL7 molecule confers resistance to MG132-and etoposide-induced apoptosis independent of p53 or Parc binding

JD Dowell, SC Tsai, DC Dias-Santagata… - … et Biophysica Acta (BBA …, 2007 - Elsevier
JD Dowell, SC Tsai, DC Dias-Santagata, H Nakajima, Z Wang, W Zhu, LJ Field
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 2007Elsevier
p193/CUL7 is an E3 ubiquitin ligase initially identified as an SV40 Large T Antigen binding
protein. Expression of a dominant interfering variant of mouse p193/CUL7 (designated
1152stop) conferred resistance to MG132-and etoposide-induced apoptosis in U2OS cells.
Immune precipitation/Western analyses revealed that endogenous p193/CUL7 formed a
complex with Parc (a recently identified parkin-like ubiquitin ligase) and p53. Apoptosis
resistance did not result from 1152stop-mediated disruption of the endogenous p193/CUL7 …
p193/CUL7 is an E3 ubiquitin ligase initially identified as an SV40 Large T Antigen binding protein. Expression of a dominant interfering variant of mouse p193/CUL7 (designated 1152stop) conferred resistance to MG132- and etoposide-induced apoptosis in U2OS cells. Immune precipitation/Western analyses revealed that endogenous p193/CUL7 formed a complex with Parc (a recently identified parkin-like ubiquitin ligase) and p53. Apoptosis resistance did not result from 1152stop-mediated disruption of the endogenous p193/CUL7 binding partners. Moreover, 1152stop molecule did not directly bind to endogenous p193/CUL7, Parc or p53. These data suggested a role for p193/CUL7 in the regulation of apoptosis independently of p53 and Parc activity.
Elsevier